Buchumschlag

Anais I Congresso Nacional de Oncologia

Fuente: Zenodo

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Editora Saúde Vital, Yasmim Santos de Oliveira, Taciele do Nascimento Santos
Format:	Recurso digital
Sprache:	Portugiesisch
Veröffentlicht:	Zenodo 2026
Schlagworte:	Anais Oncology Oncologia
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Estruturas narrativas nos Anais de Tácito
von: Juliana Bastos Marques
Veröffentlicht: (2010)

Scientific production in a pediatric oncology unit: bibliometric and scientometric evaluation
von: Félix, Francisco Hélder Cavalcante, et al.
Veröffentlicht: (2023)

A CONSTRUÇÃO DA CIDADANIA COMO ESFORÇO SIMBÓLICO E IDEOLÓGICO: A AUTOREPRESENTAÇÃO DE ÊNIO, POETA ROMANO
von: Everton da Silva Natividade
Veröffentlicht: (2010)

A pesquisa sobre o ensino de Historia nos Encontros Estaduais de Historia da ANPUH-BA: impressões iniciais*
von: Carlos Augusto Lima
Veröffentlicht: (2018)

O campo da engenharia e desenvolvimento social no Brasil
von: Celso Alexandre Souza de Alvear
Veröffentlicht: (2017)

Lectura crítica de artículos de investigación clínica en médicos residentes de oncología
von: Gabriel González-Ávila
Veröffentlicht: (2009)

Factors associated with functional disability in older adults with cancer treated at reference outpatient clinics in the state of Mato Grosso, Brazil
von: Cabral, Juliana Fernandes, et al.
Veröffentlicht: (2022)

ANALYSIS ON THE BODY IN THE ANNALS OF THE BRAZILIAN CONGRESS OF SPORT SCIENCES (CONBRACE)
von: Baptista, Tadeu João Ribeiro, et al.
Veröffentlicht: (2022)

Doença de Paget perianal extramamária: relato de caso raro e revisão da literatura
von: Gabriela Alfier
Veröffentlicht: (2024)

A Psico-Oncologia
von: Elisa Maria Parahyba Campos
Veröffentlicht: (2010)

Antibody targeting of surface P‐selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition
von: João L. Pereira, et al.
Veröffentlicht: (2024)

E‐selectin affinity glycoproteomics reveals neuroendocrine proteins and the secretin receptor as a poor‐prognosis signature in colorectal cancer
von: Sofia Cotton, et al.
Veröffentlicht: (2024)

Шалом Михайлович Тараканов - Новая наука: ОнкоПрофилактика. ОнкоПрофилактика.рф, 2025
von: Тараканов, Шалом Михайлович
Veröffentlicht: (2025)

Chemoresistance Cytological Score for Canine Transmissible Venereal Tumour: A Proposed System of Predicting Vincristine Resistance
von: Pedro Antônio Bronhara Pimentel, et al.
Veröffentlicht: (2025)

Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores
von: Erlon de Avila Carvalho, et al.
Veröffentlicht: (2025)

Recommendations of the Brazilian Society of Surgical Oncology for the Treatment of Neoplastic Pericardial Effusion
von: Erlon de Avila Carvalho, et al.
Veröffentlicht: (2024)

Lomustine, Etoposide and Cyclophosphamide as Conditioning for Auto‐HCT in Lymphomas
von: Rafaella Cabral Samico, et al.
Veröffentlicht: (2025)

“If I Can't Live as a Man, I'd Rather Not Live at All”: Older Prostate Cancer Patients Discuss Doctors' Attitudes Toward Their Sexuality
von: Shlomit Manor, et al.
Veröffentlicht: (2025)

Effects of Mobilization Within 24 Hours Based on the ICU Mobility Scale in Cancer Patients: A Randomized Controlled Clinical Trial “Mobilization Based on the ICU Mobility Scale”
von: Flaviana Santos de Sousa Silva, et al.
Veröffentlicht: (2025)

“I Am Not the One That Caused Your Illness”: Lung Cancer Stigma in Nigeria
von: Smita C. Banerjee, et al.
Veröffentlicht: (2025)

“If I have a limited amount of time left, this is not how I want to spend it”: A qualitative descriptive study of factors influencing daily life participation following a cancer diagnosis
von: Nirmala Shivakumar, et al.
Veröffentlicht: (2024)

689 | HOW TO OPTIMIZE THE USE OF HIGH‐COST THERAPIES IN DLBCL: A COLLABORATIVE OBSERVATIONAL STUDY BY THE URUGUAYAN LYMPHOMA GROUP
von: M. V. Irigoin, et al.
Veröffentlicht: (2025)

Optimizing Fixed‐Duration Ven‐I Regimen in CLL: Expert Insight and AI Comparison
von: V. Innao, et al.
Veröffentlicht: (2026)

The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer
von: Adi Alfandari, et al.
Veröffentlicht: (2024)

Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759
von: Marc Pujalte‐Martin, et al.
Veröffentlicht: (2024)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer
von: Yuho Ebata, et al.
Veröffentlicht: (2026)

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil
von: Radhika Sain, et al.
Veröffentlicht: (2026)

“I couldn't connect the wires in my brain.” Young adult cancer survivors' experience with cognitive functioning
von: Danielle B. Tometich, et al.
Veröffentlicht: (2024)

Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti‐tumor efficacy
von: Yasmin Yu, et al.
Veröffentlicht: (2024)

799 | MHC‐I UPREGULATION SAFEGUARDS NEOPLASTIC T CELLS IN THE SKIN AGAINST NK CELL‐MEDIATED ERADICATION IN MYCOSIS FUNGOIDES
von: E. Guenova
Veröffentlicht: (2025)

Landscape Review and Economic Potential of the Oncology and Allied Digital Health Sector on the Island of Ireland
von: Raymond Henderson, et al.
Veröffentlicht: (2024)

Clustering Based on Innate Immunity Reveals Differential Dysregulation Based on Disease Severity in Myelodysplastic Neoplasms
von: Pedro Robson Costa Passos, et al.
Veröffentlicht: (2025)

Insomnia in Patients With Cancer: Challenges and Management Strategies
von: Cristiane Decat Bergerot, et al.
Veröffentlicht: (2025)

815 | GLOFITAMAB MONOTHERAPY IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: FINAL ANALYSIS OF A PHASE I TRIAL
von: Y. Song, et al.
Veröffentlicht: (2025)

818 | INTERIM ANALYSIS OF POMALIDOMIDE PLUS RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN RELAPSED/REFRACTORY DLBCL: A PHASE I/II STUDY (PRIDE STUDY)
von: P. Xu, et al.
Veröffentlicht: (2025)

112 | PHASE I STUDY OF SPLIT‐COURSE BRIDGING RADIOTHERAPY (SC‐BRT) PRIOR TO CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY B‐CELL LYMPHOMAS
von: B. S. Imber, et al.
Veröffentlicht: (2025)

Association of radiation‐induced epilation and interventional neuroradiology procedures
von: Deborah Carrick, et al.
Veröffentlicht: (2024)

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ ALL pediatric patients with high minimal residual disease
von: Antonio Lahera, et al.
Veröffentlicht: (2026)

568 | REAL‐WORLD DATA ANALYSIS WITH INFORMATICS FOR INTEGRATING BIOLOGY AND THE BEDSIDE (I2B2): A RELIABLE TOOL FOR EVIDENCE GENERATION IN FOLLICULAR LYMPHOMA
von: G. Gritti, et al.
Veröffentlicht: (2025)

Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD‐L1 ‐expressing head and neck cancer
von: Jeon Yeob Jang, et al.
Veröffentlicht: (2024)